Patent · US Active

Ophthalmic compositions comprising ciclosporin

US11400132B2 · kind B2 · utility

3Cited by

63References

14Claims

0Family size

Assignee

NOVALIQ GMBH · DE

Inventors

Frank LÖSCHER · Schriesheim, DE
Ralf GRILLENBERGER · Nuremberg, DE
Johan Engblom · Lund, SE

Key dates

Filing date	Oct 13, 2020
Grant date	Aug 2, 2022
Priority date	—
Expiry date	Oct 13, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions in the form of a clear solution comprising ciclosporin with low residual water content and 1-perfluorobutyl-pentane. The compositions may be used for topical administration to the eye.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.